CUTANEOUS ADVERSE REACTIONS ASSOCIATED WITH CALCIUM-CHANNEL BLOCKERS

被引：68

作者：

STERN, R ^{[1
]}

KHALSA, JH ^{[1
]}

机构：

[1] US FDA,RES OFF EPIDEMIOL & BIOSTAT,ROCKVILLE,MD 20857

来源：

关键词：

D O I：

10.1001/archinte.149.4.829

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：829 / 832

页数：4

共 11 条

[1] CUTANEOUS REACTIONS TO NIFEDIPINE
ALCALAY, J
DAVID, M
SANDBANK, M
[J]. DERMATOLOGICA, 1987, 175 (04): : 191 - 193
[2] ALCALAY J, 1986, BRIT MED J, V292, P450
[3] NATIONAL ADVERSE DRUG REACTION SURVEILLANCE - 1985
FAICH, GA
KNAPP, D
DREIS, M
TURNER, W
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (15): : 2068 - 2070
[4] HYPERPLASTIC GINGIVITIS DURING DILTIAZEM THERAPY
GIUSTINIANI, S
DELLACUNA, FR
MARIENI, M
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1987, 15 (02) : 247 - 249
[5] HASHIMOTO M, 1979, ACTA DERMATOL KYOTO, V74, P181
[6] GINGIVAL HYPERPLASIA ASSOCIATED WITH NIFEDIPINE
JONES, CM
[J]. BRITISH DENTAL JOURNAL, 1986, 160 (12) : 416 - 417
[7] LAVRIJSEN APM, 1986, ACTA DERM-VENEREOL, V66, P536
[8] MYRHED M, 1986, ACTA PHARMACOL TOX, V58, P133
[9] A GOLDEN OPPORTUNITY
WEARY, PE
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1980, 3 (06) : 647 - 648
[10] 1985, NATIONAL PRESCRIPTIO